Cellid, Co., Ltd. (299660.KQ)

KRW 3965.0

(12.01%)

Operating Expenses Summary of Cellid, Co., Ltd.

Cellid, Co., Ltd.'s latest annual operating expenses in 2023 was 10.97 Billion KRW , down -1.81% from previous year.
Cellid, Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 2.65 Billion KRW , up 40.41% from previous quarter.
Cellid, Co., Ltd. reported a annual operating expenses of 12.53 Billion KRW in annual operating expenses 2022, down -38.29% from previous year.
Cellid, Co., Ltd. reported a annual operating expenses of 20.31 Billion KRW in annual operating expenses 2021, up 323.61% from previous year.
Cellid, Co., Ltd. reported a quarterly operating expenses of 2.65 Billion KRW for 2024 Q2, up 40.41% from previous quarter.
Cellid, Co., Ltd. reported a quarterly operating expenses of 2.58 Billion KRW for 2023 Q1, up 48.56% from previous quarter.

Annual Operating Expenses Chart of Cellid, Co., Ltd. (2023 - 2015)

Historical Annual Operating Expenses of Cellid, Co., Ltd. (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	10.97 Billion KRW	-1.81%
2022	12.53 Billion KRW	-38.29%
2021	20.31 Billion KRW	323.61%
2020	4.79 Billion KRW	4.91%
2019	4.57 Billion KRW	14.99%
2018	3.97 Billion KRW	74.18%
2017	2.28 Billion KRW	32.36%
2016	1.72 Billion KRW	-5.21%
2015	1.81 Billion KRW	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	1.89 Billion KRW	-19.12%
2024 Q2	2.65 Billion KRW	40.41%
2023 Q1	2.58 Billion KRW	48.56%
2023 FY	12.3 Billion KRW	-1.81%
2023 Q4	2.34 Billion KRW	-27.96%
2023 Q3	3.24 Billion KRW	-12.5%
2023 Q2	3.71 Billion KRW	43.74%
2022 Q4	1.73 Billion KRW	-67.29%
2022 FY	12.53 Billion KRW	-38.29%
2022 Q1	4.9 Billion KRW	-18.4%
2022 Q3	5.31 Billion KRW	-15.49%
2022 Q2	6.28 Billion KRW	28.08%
2021 Q3	4.56 Billion KRW	-15.73%
2021 Q4	6.01 Billion KRW	31.86%
2021 Q1	2.34 Billion KRW	29.59%
2021 Q2	5.41 Billion KRW	130.48%
2021 FY	20.31 Billion KRW	323.61%
2020 Q4	1.81 Billion KRW	24.53%
2020 Q1	1.73 Billion KRW	49.56%
2020 Q2	214.62 Million KRW	-87.64%
2020 Q3	1.45 Billion KRW	578.2%
2020 FY	4.79 Billion KRW	4.91%
2019 Q1	569.4 Million KRW	-42.12%
2019 FY	4.57 Billion KRW	14.99%
2019 Q4	1.16 Billion KRW	44.39%
2019 Q3	804.18 Million KRW	-8.69%
2019 Q2	880.75 Million KRW	54.68%
2018 Q2	2.62 Billion KRW	-64.12%
2018 FY	3.97 Billion KRW	74.18%
2018 Q1	7.3 Billion KRW	450.23%
2018 Q4	983.78 Million KRW	0.0%
2017 FY	2.28 Billion KRW	32.36%
2017 Q1	1.26 Billion KRW	0.0%
2017 Q4	1.32 Billion KRW	0.0%
2016 FY	1.72 Billion KRW	-5.21%
2015 FY	1.81 Billion KRW	0.0%

Peer Operating Expenses Comparison of Cellid, Co., Ltd.

Name	Operating Expenses	Operating Expenses Difference
Sam Chun Dang Pharm. Co., Ltd	84.83 Billion KRW	87.063%
Hyundai Bioscience Co., Ltd.	14.82 Billion KRW	25.973%
ST Pharm Co.,Ltd.	75.59 Billion KRW	85.481%
ABL Bio Inc.	65.52 Billion KRW	83.251%